Nutrition 21, LLC Settles IP Suit With CVS Pharmacy, Inc.

NUTRITION 21, LLC ANNOUNCES THE SETTLEMENT OF A PATENT INFRINGEMENT LAWSUIT CONCERNING CHROMIUM PICOLINATE

Nutrition 21, LLC Settles IP Suit With CVS Pharmacy, Inc.

PURCHASE, NEW YORK – NOVEMBER 19th, 2015 – JDS Therapeutics, LLC and Nutrition 21, LLC (“Nutrition 21”) announced that they have entered into a confidential settlement and license agreement with CVS Pharmacy, Inc. (“CVS”).  The settlement ends a patent infringement lawsuit brought by Nutrition 21 against CVS in the Southern District of New York related to products sold by CVS that include chromium picolinate in certain combinations and for certain uses.  The financial terms of the settlement are confidential. 

Read the full press release here – Nutrition 21, LLC Settles IP Suit With CVS Pharmacy, Inc.